Risperidone and Falls in Ambulatory Nursing Home Residents With Dementia and Psychosis or Agitation: Secondary Analysis of a Double-Blind, Placebo-Controlled Trial

2004 ◽  
Vol 12 (5) ◽  
pp. 499-508 ◽  
Author(s):  
Ira R. Katz ◽  
Marcia Rupnow ◽  
Chris Kozma ◽  
Lon Schneider
Keyword(s):  
Nursing Home ◽  
Controlled Trial ◽  
Secondary Analysis ◽  
Nursing Home Residents ◽  
Double Blind ◽  
Double Blind Placebo

Antipsychotic Treatment in Outpatients With Dementia

1997 ◽  
Vol 8 (S3) ◽  
pp. 355-361 ◽  
Author(s):  
D. P. Devanand
Keyword(s):  
Nursing Home ◽  
Nursing Home Residents ◽  
Antipsychotic Treatment ◽  
Controlled Trials ◽  
Neuroleptic Drugs ◽  
Behavioral Disturbances ◽  
Double Blind ◽  
Double Blind Placebo ◽  
The Past

Uncontrolled reports suggest that 25% to 75% of patients with behavioral disturbances of dementia respond to conventional neuroleptic drugs. Yet during the past 20 years, results from only four randomized, double-blind, placebo-controlled trials of neuroleptics in dementia have been published. These studies were conducted in hospitalized inpatients or nursing home residents.

scholarly journals Thiamine as a Renal Protective Agent in Septic Shock. A Secondary Analysis of a Randomized, Double-Blind, Placebo-controlled Trial

2017 ◽  
Vol 14 (5) ◽  
pp. 737-741 ◽  
Author(s):  
Ari Moskowitz ◽  
Lars W. Andersen ◽  
Michael N. Cocchi ◽  
Mathias Karlsson ◽  
Parth V. Patel ◽  
...  
Keyword(s):  
Septic Shock ◽  
Controlled Trial ◽  
Secondary Analysis ◽  
Protective Agent ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document